Cytori sees profitablity through medical device classification

06/26/2007 | TheStreet.com

Cytori Therapeutics is taking a shorter route to profitability than many other stem cell companies by seeking approval for products as medical devices. The company hopes to get regulatory approval this year for a device that can withdraw stem cells from a patient's own fat for use in other parts of the body.

View Full Article in:

TheStreet.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA